Detalhe da pesquisa
1.
Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products-induced inflammation.
Kidney Int
; 105(1): 132-149, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38069998
2.
RAGE antagonism with azeliragon improves xenograft rejection by T cells in humanized mice.
Clin Immunol
; 245: 109165, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36257528
3.
Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting Myelopoiesis.
Circ Res
; 127(7): 877-892, 2020 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32564710
4.
The impact of a modified carbohydrate formula, and its constituents, on glycaemic control and inflammatory markers: A nested mechanistic sub-study.
J Hum Nutr Diet
; 35(3): 455-465, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34743379
5.
Targeting the receptor for advanced glycation end products (RAGE) in type 1 diabetes.
Med Res Rev
; 40(4): 1200-1219, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32112452
6.
Mechanisms of diabetic complications.
Physiol Rev
; 93(1): 137-88, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23303908
7.
Prolyl hydroxylase inhibitors: a breath of fresh air for diabetic kidney disease?
Kidney Int
; 97(5): 855-857, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32331596
8.
Delineating a role for the mitochondrial permeability transition pore in diabetic kidney disease by targeting cyclophilin D.
Clin Sci (Lond)
; 134(2): 239-259, 2020 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31943002
9.
Genetic characterization of early renal changes in a novel mouse model of diabetic kidney disease.
Kidney Int
; 96(4): 918-926, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31420193
10.
Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products.
Int J Mol Sci
; 20(20)2019 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31614491
11.
Vascular complications in diabetes: old messages, new thoughts.
Diabetologia
; 60(11): 2129-2138, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28725914
12.
Disparity in the micronutrient content of diets high or low in advanced glycation end products (AGEs) does not explain changes in insulin sensitivity.
Int J Food Sci Nutr
; 68(8): 1021-1026, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28460575
13.
Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes.
Clin Sci (Lond)
; 130(9): 711-20, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26831938
14.
Targeting advanced glycation with pharmaceutical agents: where are we now?
Glycoconj J
; 33(4): 653-70, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27392438
15.
Diabetic kidney disease: a role for advanced glycation end-product receptor 1 (AGE-R1)?
Glycoconj J
; 33(4): 645-52, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27270766
16.
Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis.
Curr Diab Rep
; 16(10): 100, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27612847
17.
Effects of high-density lipoprotein elevation with cholesteryl ester transfer protein inhibition on insulin secretion.
Circ Res
; 113(2): 167-75, 2013 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23676183
18.
Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes.
Diabetologia
; 57(9): 1977-85, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24957662
19.
Dietary glycotoxins exacerbate progression of experimental fatty liver disease.
J Hepatol
; 60(4): 832-8, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24316518
20.
Advanced glycation end products (AGEs) are cross-sectionally associated with insulin secretion in healthy subjects.
Amino Acids
; 46(2): 321-6, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23832534